Boiron SA (0DTF.L)
EUR 27.0
(-0.37%)
EUR 27.0
(-0.37%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 6.64 Million EUR | -42.54% |
| 2022 | 11.56 Million EUR | 392.71% |
| 2021 | 2.34 Million EUR | -28.71% |
| 2020 | 3.29 Million EUR | -27.43% |
| 2019 | 4.53 Million EUR | 7.85% |
| 2018 | 4.2 Million EUR | -12.25% |
| 2017 | 4.79 Million EUR | -5.18% |
| 2016 | 5.05 Million EUR | 8.08% |
| 2015 | 4.67 Million EUR | 11.38% |
| 2014 | 4.19 Million EUR | 23.25% |
| 2013 | 3.4 Million EUR | 5.64% |
| 2012 | 3.22 Million EUR | 5.77% |
| 2011 | 3.04 Million EUR | 15.27% |
| 2010 | 2.64 Million EUR | 42.74% |
| 2009 | 1.85 Million EUR | 19.24% |
| 2008 | 1.55 Million EUR | -5.19% |
| 2007 | 1.63 Million EUR | -90.55% |
| 2006 | 17.34 Million EUR | -14.55% |
| 2005 | 20.29 Million EUR | 844.25% |
| 2004 | 2.14 Million EUR | -60.72% |
| 2003 | 5.47 Million EUR | 14.17% |
| 2002 | 4.79 Million EUR | 4.88% |
| 2001 | 4.56 Million EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 34 Thousand EUR | 0.0% |
| 2023 Q2 | 483 Thousand EUR | 0.0% |
| 2023 Q4 | 6.64 Million EUR | 0.0% |
| 2023 FY | 6.64 Million EUR | -42.54% |
| 2022 FY | 11.56 Million EUR | 392.71% |
| 2022 Q4 | 11.56 Million EUR | 0.0% |
| 2022 Q2 | 15.02 Million EUR | 0.0% |
| 2021 Q4 | 2.34 Million EUR | 0.0% |
| 2021 Q2 | 2.4 Million EUR | 0.0% |
| 2021 FY | 2.34 Million EUR | -28.71% |
| 2020 FY | 3.29 Million EUR | -27.43% |
| 2020 Q2 | 3.4 Million EUR | 0.0% |
| 2020 Q4 | 3.29 Million EUR | 0.0% |
| 2019 Q2 | 4.64 Million EUR | 0.0% |
| 2019 Q4 | 4.53 Million EUR | 0.0% |
| 2019 FY | 4.53 Million EUR | 7.85% |
| 2018 Q2 | 4.35 Million EUR | 0.0% |
| 2018 Q4 | 4.2 Million EUR | 0.0% |
| 2018 FY | 4.2 Million EUR | -12.25% |
| 2017 Q4 | 4.79 Million EUR | 0.0% |
| 2017 FY | 4.79 Million EUR | -5.18% |
| 2017 Q2 | 4.9 Million EUR | 0.0% |
| 2016 FY | 5.05 Million EUR | 8.08% |
| 2016 Q4 | 5.05 Million EUR | 0.0% |
| 2016 Q2 | 5.21 Million EUR | 0.0% |
| 2015 Q4 | 4.67 Million EUR | 0.0% |
| 2015 Q2 | 4.86 Million EUR | 0.0% |
| 2015 FY | 4.67 Million EUR | 11.38% |
| 2014 Q4 | 4.19 Million EUR | 0.0% |
| 2014 FY | 4.19 Million EUR | 23.25% |
| 2014 Q2 | 4.26 Million EUR | 0.0% |
| 2013 Q2 | 3.72 Million EUR | 0.0% |
| 2013 Q4 | 3.4 Million EUR | 0.0% |
| 2013 FY | 3.4 Million EUR | 5.64% |
| 2012 Q2 | 3.34 Million EUR | 0.0% |
| 2012 Q1 | 3.34 Million EUR | 9.64% |
| 2012 Q4 | 3.22 Million EUR | 0.0% |
| 2012 FY | 3.22 Million EUR | 5.77% |
| 2012 Q3 | 3.22 Million EUR | -3.53% |
| 2011 Q2 | 3.17 Million EUR | 0.0% |
| 2011 FY | 3.04 Million EUR | 15.27% |
| 2011 Q4 | 3.04 Million EUR | 0.0% |
| 2010 Q4 | 2.64 Million EUR | 0.0% |
| 2010 FY | 2.64 Million EUR | 42.74% |
| 2010 Q2 | 2.8 Million EUR | 0.0% |
| 2009 Q4 | 1.85 Million EUR | 0.0% |
| 2009 FY | 1.85 Million EUR | 19.24% |
| 2008 FY | 1.55 Million EUR | -5.19% |
| 2007 FY | 1.63 Million EUR | -90.55% |
| 2006 FY | 17.34 Million EUR | -14.55% |
| 2005 FY | 20.29 Million EUR | 844.25% |
| 2004 FY | 2.14 Million EUR | -60.72% |
| 2003 FY | 5.47 Million EUR | 14.17% |
| 2002 FY | 4.79 Million EUR | 4.88% |
| 2001 FY | 4.56 Million EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Laboratorios Farmaceuticos Rovi, S.A. | 38.57 Million EUR | 82.774% |
| Vetoquinol SA | 9.66 Million EUR | 31.233% |
| Valneva SE | 132.76 Million EUR | 94.995% |
| AB Science S.A. | 16.98 Million EUR | 60.884% |
| Nanobiotix S.A. | 41.66 Million EUR | 84.049% |
| PHAXIAM Therapeutics S.A. | 7.03 Million EUR | 5.477% |
| Vivoryon Therapeutics N.V. | - EUR | -Infinity% |
| BioSenic S.A. | 15.57 Million EUR | 57.33% |
| ABIVAX Société Anonyme | 44.69 Million EUR | 85.133% |
| Formycon AG | 7.81 Million EUR | 14.971% |